Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: L... Tekijä Lisa M Butler, Anthony M Joshua, Tahlia Scheinberg, James Kench, Martin Stockler, Kate L Mahon, Lucille Sebastian, Phillip Stricker, H Woo, Ruban Thanigasalam, Nariman Ahmadi, Margaret M Centenera, Lisa G Horvath

Hae kokoteksti